These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37204716)

  • 21. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Controversies in Lupus Anticoagulant Detection.
    Moore GW
    Antibodies (Basel); 2016 Dec; 5(4):. PubMed ID: 31558003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical applications of snake venom toxins in haemostasis.
    Marsh N; Williams V
    Toxicon; 2005 Jun; 45(8):1171-81. PubMed ID: 15922782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different Anticoagulants.
    Khan W; Tormey CA; Rinder HM; Siddon AJ
    Am J Clin Pathol; 2023 May; 159(5):417-419. PubMed ID: 36940149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of lupus anticoagulant in the era of direct oral anticoagulants.
    Hoxha A; Banzato A; Ruffatti A; Pengo V
    Autoimmun Rev; 2017 Feb; 16(2):173-178. PubMed ID: 27988438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant snake venom prothrombin activators.
    Lövgren A
    Bioengineered; 2013; 4(3):153-7. PubMed ID: 23111318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic uses of snake venom.
    Marsh NA
    Haemostasis; 2001; 31(3-6):211-7. PubMed ID: 11910187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome.
    Efthymiou M; Bertolaccini ML; Cohen H
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI54-SI63. PubMed ID: 38320587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixing studies for lupus anticoagulant: mostly yes, sometimes no.
    Favaloro E
    Clin Chem Lab Med; 2020 Mar; 58(4):487-491. PubMed ID: 31874094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ; Mohammed S; Curnow J; Pasalic L
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of snake venom fractions in the coagulation laboratory.
    Marsh NA
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):395-404. PubMed ID: 9712287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
    Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H
    J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.